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Phage display as a powerfull tool to engineer novel biomaterials for diverse regenerative medicine 
applications.  
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ABSTRACT 
The field of regenerative medicine has been gaining momentum steadily over the past 
few years. The emphasis in regenerative medicine is to use various in-vitro and in-vivo 
approaches that leverage on the intrinsic healing mechanisms of the body to treat 
patients with disabling injuries and chronic diseases such as diabetes, osteoarthritis, 
and degenerative disorders of the cardiovascular and central nervous system. 
Phage display has been successfully employed to identify peptide ligands for a wide 
variety of targets, ranging from relatively small molecules (enzymes, cell receptors) to 
inorganic, organic, and biological (tissues) materials. Over the last two decades, phage 
display technology has advanced tremendously and has become a powerful tool in the 
most varied fields of research, including biotechnology, materials science, cell biology, 
pharmacology, and diagnostics. The growing interest in and success of phage display 
libraries is largely due its incredible versatility and practical use. This review discusses 
the potential of phage display technology in biomaterials engineering for applications 
in regenerative medicine. 
 
 
KEYWORDS 
 
Bacteriophages (or phages): viruses that specifically infect bacterial cells and consist of an 
outer protein capsid enclosing genetic material (dsDNA - vast majority, ssDNA, ssRNA, or 
dsRNA - very rare, with either circular or linear arrangement).  
 
Biomaterials: synthetic or natural materials designed to interact with tissues and organs in the 
body to monitor and/or restore their functions. 
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Nanotechnology: technology that involves imaging, measuring, modeling, and manipulating 
materials on the nanometer scale (i.e. 10
-9
 meter), typically in the range of 1 to 100 
nanometers.  
Peptide ligand: a peptide sequence which binds with high affinity and specificity to a particular 
target. 
 
Phage display panning: combinatorial process of displaying random peptide sequences or 
engineered proteins, fused to the coat-proteins on the surface of phages, to identify peptides 
or proteins (out of billions of candidates) that bind specifically and selectively to a defined or 
unknown target.  
 
Phage display peptide library: collection of phage particles displaying random peptides 
containing as many as 10
9
 combinations.  
 
Regenerative medicine: new field in the health sciences dedicated to the regeneration of 
tissues or organs by applying specific cell populations or biomaterial scaffolds, alone or 
combined, to stimulate the intrinsic healing ability of the body and promote endogenous 
repair. 
 
Targeted delivery: method of delivering a therapeutic (drug, bioactive protein, or gene) or 
imaging (probe) agent to a specific site in the body, which optimizes its therapeutic or imaging 
index by restricting its pharmacological or imaging activity to the target tissue or organ, and 
reducing potential exposure in unwanted sites.  
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INTRODUCTION 
Regenerative medicine (RM) is a growing field of interdisciplinary research and clinical 
practices that has the potential of transforming the future of healthcare. It seeks to 
repair or replace malfunctioning cells, tissues, or organs caused by genetic disorders, 
chronic diseases, injuries or aging (1). It employs a combination of in-vitro/ex-vivo and 
in-vivo approaches that may involve transplantation of stem/progenitor, 
differentiated, or engineered cells, alone or incorporated in biomaterial scaffolds; 
tissue engineering; and delivery of therapeutic agents (e.g. cytokines, genes, small 
molecules) for reprogramming cell and tissue types or improving the function of the 
host environment. All RM strategies leverage on the stimulation of the body’s 
endogenous processes to develop and repair. Accordingly, stem cell research, gene 
therapy, biomaterials science, and molecular imaging play a central role in RM.  
Phage display is a potent, high-throughput technology used for identifying peptide 
ligands for a given target. The technique applies a library of phage particles displaying 
an ample variety of peptides or proteins to identify those that bind to a certain target. 
The utility of this technology derives from phage biology, as phages can be genetically 
modified to express polypeptides on their surface while the gene encoding the 
polypeptide, found inside the viral particle, can be analyzed. Since its first 
establishment by George P. Smith in 1985 (2), phage display has enabled the selection 
of a vast quantity of different peptides. Although being mostly used to discover 
peptide ligands for mapping protein–protein interactions, and in the field of antibody 
engineering, phage display has evolved, now contributing to a variety of different 
areas of medicine and technology. Some of those areas that now benefit from the 
system are molecular and imaging diagnosis (3), peptide drug discovery (4), targeted 
drug and gene delivery (5), vaccine development (6), identification of new receptors 
and ligands (6), and nanomaterials (7, 8). Several excellent reviews, covering different 
aspects of phages, including phage biology (9) and the application of phage display in 
different areas (6, 10-12) have been published.  
Cell transplantation often requires prior expansion of the cells in-vitro to obtain large 
numbers of functional cells for clinical applications. Thus in-vitro expansion is a critical 
step in cell-based therapies and typically involves the culture of cells on substrates 
coated with extracellular matrix (ECM) proteins. However, the batch-to-batch 
variability of ECM proteins presents limitations for both basic research and clinical 
applications of stem cells. Phage display technology provides a non-expensive tool for 
the rapid and efficient screening of peptide ligands on cells or tissues, discriminating 
between subtle differences in cell surface phenotypes and between normal or 
diseased tissues. These peptide motifs can be incorporated into biomaterials to guide 
stem cell proliferation and differentiation in-vitro for subsequent transplantation, or to 
recruit local stem cells in-vivo for stimulating tissue regeneration. Using phage-derived 
peptides targeting specific cells or tissues, rather than the non-specific peptide motifs 
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routinely used in RM approaches, more controllable and effective regenerative 
therapies can be developed and tailored to individual patients, leading towards 
personalized medicine. In addition, phage display can provide novel peptides to 
investigate peptide–protein interactions that underlie disease mechanisms, which can 
be further used for designing potential therapeutic agents. Thus, peptide phage display 
is also a valuable tool in RM, and several therapeutic products generated by this 
technology are now commercially available (4), demonstrating its clinical potential. 
This review aims to recount the applications of phage display in biomaterials 
engineering and RM, highlighting the future of phage display in these fields. 
 
Phage display screening - biopanning 
The most common screening method to identify peptide ligands for a given target by 
phage display (affinity selection) is known as biopanning. This procedure employs a 
phage display library that consist of a pool of individual clones (∼ 10
9
) bearing a 
different foreign DNA insert in the phage genome and presenting a different peptide 
on its surface. The external gene sequence is merged between genes encoding a signal 
peptide and a part of the capsid protein, which ensures that the foreign peptide is 
expressed fused to the coat-proteins. Molecules displayed on phage libraries are not 
restricted to peptides and antibodies. Random protein fragments, gene fragment- or 
cDNA-encoded proteins, and mRNA phage display libraries have also been created (13, 
14), broadening the practical applications of the technology and demonstrating the 
versatility of the technology. 
Typically, the process starts with library exposure to the target of interest to allow 
binding to the target under suitable conditions. The loosened phages are eliminated by 
washing, and the remaining bound phages are then eluted for subsequent bacterial 
infection and amplification. Viral multiplication occurs within the host cells, and 
thousands of newly-formed phage particles are generated for additional selection 
rounds (usually 2–5 rounds). After multiple panning rounds, enrichment of target-
binding phage is analyzed by phage tittering and/or immunological assays. When 
sufficient enrichment is achieved, single phages are separated and sequenced to 
identify predominant binding motifs (consensus sequence). Selective clones may be 
obtained by examining the differences between unselected and selected libraries using 
DNA sequencing (15, 16). 
Selection of ligands able to distinguish particular features in biological scenarios (cells 
and tissues) with good specificity and affinity is required for reliable diagnosis and 
effective regenerative therapies. Thus, potential targets in RM are signaling proteins 
(e.g. growth factors), cells, and tissues. These targets, however, have many potential 
binding sites, and non-specific binding to abundant molecules (e.g. albumin) is also 
believed to affect the outcome of the panning experiments. Hamilton and co-workers 
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(17) described the application of phage display to select peptides that bind to bone 
morphogenetic protein 2 (BMP-2), which is implicated in osteoblast differentiation and 
stimulates bone formation. Using a recombinant form of human BMP-2 (rhBMP-2), 
they first biotinylated the protein for immobilization on streptavidin (SA)-coated 
microtiter plates. Biopanning was performed according to conventional protocols. 
After 3 cycles of screening, the populations of enriched phages were amplified in 
bacteria and the binding to BMP-2 was detected by an enzyme linked immunosorbent 
assay (ELISA). 
Many studies do not take into account the fact that the high density of receptors at the 
selection surface does not reproduce the density of receptors present on the native 
cell membrane. Thus, the binding affinity of the isolated peptide might be lower than 
the one observed when displayed on the phage. For example, Bastings et al. (18) 
demonstrated, using SA as a model multivalent receptor, that receptor density and 
ligand valency are important parameters associated with binding strength. They 
showed that phage affinity for SA-coated surfaces declines significantly into the 
nanomolar scale when the surface density of SA is reduced. By displaying the peptide 
ligand in a multivalent arrangement (e.g. dimer, tetramer, or pentameric peptide 
wedge) they were able to increase (104-fold) the binding affinity as compared to the 
monovalent peptide. This study suggests that for effective targeting strategies, both 
the ligand presentation and the density of the corresponding receptor are 
fundamental aspects to consider. The ligand selection should be conducted on surfaces 
with physiologically-representative receptor densities, and the peptides identified by 
phage display should be displayed in an appropriate form (e.g. dendrimer) when 
engineering biomaterials aiming for successful targeting. In addition, the cell surface 
contains proteins that can cluster or multimerize, and some of these organization 
patterns can be disturbed upon preparation of membrane proteins for selective 
screening. Indeed, the hydrophobic segments of membrane proteins direct them into a 
lipophilic environment, with such proteins naturally aggregating after separation from 
the membrane. Recombinant forms of these proteins have been widely used, but 
recombinant receptors are not always available. Hajduczki et al. (19) proposed a new 
approach for the solubilization and presentation of membrane proteins, by proposing 
a different strategy for phage display selection. They prepared a phage library 
displaying caveolin-1 (monotopic membrane protein associated with detergent-
insoluble rafts) variants generated by site-directed mutagenesis, and used an anti-
selection process, consisting of binding to a hydrophobic resin, to eliminate 
aggregation-prone hydrophobic variants. The less hydrophobic variants were 
subsequently recovered and used in positive selection to isolate variants binding to the 
gp41 ectodomain (a known caveolin function). This additional positive panning 
ensured that the obtained variants were correctly folded. Thus, phage display 
screening on whole cells offers more chances to obtain peptides that bind to 
transmembrane proteins in their natural conformation. Panning on living cells can be 
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done either on monolayers of attached cells or on cells in suspension. In these cases, 
the pool of target-binding phages needs to be diverse, but it can be reduced by 
performing a negative screening (pre-clearing) on “control” cells (20) or a funnel 
screening protocol. Kiessling’s group (21) used a screening approach based on the 
biopanning and rapid analysis for selective interactive ligands (BRASIL) method, 
previously developed by Giordano and co-workers (20), to isolate peptides binding to 
the surface of live stem cells. BRASIL is more specific (panning of cells in suspension) 
and faster than conventional methods that depend on washing or limiting dilution. 
Because living stem cells present many different receptors on their surfaces, and no 
appropriate “control cells” were available for a negative selection step, they further 
optimized the screening to narrow down the pool of cell-binding peptides. They 
incubated the cells (human embryonal carcinoma cell line) with a mixture (1:1) of 
peptide-bearing (library) and peptide-free (wild type) phage, and monitored phage 
titer at each panning and washing step. The phage members that remained bound to 
cells after all washing stages were then subjected to an additional cycle of incubation 
and washing, resulting in 50-fold enrichment of the peptide-containing phage. 
However, many non-specific phages remained in the pool. Therefore, to select the cell-
binding phage, they employed another screening step using an ELISA. Seven cell-
binding phage clones were isolated from the 370 clones tested. 
Since the human body is made of around 1014 cells with distinct types and the surface 
changes with the state of the cell, the problem gains further complexity in-vivo. 
Although most biopanning experiments are conducted in-vitro, it is recognized that the 
in-vivo conditions greatly influences the expression of cell surface molecules, and that 
the phenotype of certain cells changes when they are cultured in-vitro. Thus, the 
application of phage display selection in-vivo circumvents these challenges and allows 
the identification of ligands able of homing to specific tissues or organs (6, 22-25). In 
order to achieve this process, phage libraries are injected intravenously into animals 
and allowed to circulate for a certain time. While nonspecific phages tend to be found 
throughout the whole organism, phages with selective binding will concentrate in 
certain tissues or organs. The bound phages are recovered and amplified and their 
DNA is sequenced. Pasqualini and Ruoslahti (24) were the first to report this approach, 
isolating peptides that home to renal and cerebral vascular endothelium in-vivo. In-
vivo panning has also been applied to identify peptide ligands with potential 
applications in RM. For example, Nowakowski et al. (26) were the first to conduct a 
phage display experiment involving the bone marrow and stem cells. They injected the 
phage display library into the tail vein of mice and, 10 minutes after injection, isolated 
the bone marrow to elute phages bound to bone marrow cells. The eluted phages 
were purified, amplified, and then reinjected. Five rounds of screening resulted in the 
identification of a peptide that preferentially homes to bone marrow, also binding to 
resident hematopoietic stem cells. The receptor of this peptide may be involved in 
bone marrow engraftment by recruiting hematopoietic stem cells. 
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One of the most laborious and costly steps (rate-limiting) in phage display screening is 
the DNA sequencing of the encoded displayed peptides. Next generation sequencing 
(NGS), such as Illumina deep sequencing technology, permits a high-throughput and 
cost-competitive phage display selection because it can characterize over 10
7
 reads in 
a single run, providing more complete coverage of the libraries (27). This is particularly 
useful for panning on RM targets such as cells, which present hundreds of different 
receptors. For example, Hoen and colleagues (28) applied NGS to analyze the phage 
library at different stages of the selection process when panning on KS483 osteoblast 
cells, finding positive hits after one round of selection. Since its first application, NGS 
has been applied to enhance phage display protocols (28-31), allowing the isolation of 
phage binders after the first biopanning round, and the selection of less frequent but 
more specific peptides. As an example, a new method for selection against targets 
located on the cell surface, which are less abundant and cannot be purified, was 
implemented by the Lerner lab (32). This method allows for the identification of 
ligands for less-fit molecules with lower affinity. Having ligands with lower affinity can 
be useful for neutralizing the function/activity of the target through binding to 
different regions.  
In the following sections, we describe applications of phage-derived peptides in the 
functionalization of novel biomaterials with potential implications in RM strategies. 
 
APPLICATIONS OF PHAGE DISPLAY IN BIOMATERIALS ENGINEERING FOR 
REGENERATIVE MEDICINE  
The advances in phage display have greatly expanded the applications of the 
technology, creating new opportunities in biomaterials engineering and RM. Figure 1 
shows examples of in-vitro and in-vivo RM strategies using different biomaterial 
systems functionalized with peptides identified by phage display. Phage-derived 
peptides, able to bind specifically to receptors on the surface of stem cells, can be used 
to functionalize synthetic scaffolds (2D surfaces and 3D hydrogels) for promoting stem 
cell expansion (Figure 1-a) or differentiation (Figure 1-b) in-vitro. In-vivo approaches 
include the incorporation of peptide ligands identified by phage display into injectable 
biomaterials (e.g. nanofibers), which can bind to growth factors (GFs) and promote 
endogenous tissue repair (Figure 1-c), or into nanobiomaterials (e.g. liposomes, 
dendrimers), which can bind to receptors on the cell surface and deliver genetic 
material to target cells (gene therapy, Figure 1-d). 
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 Figure 1. The use of phage display (center: M13 phage displaying a random peptide library on coat-
protein 3) in biomaterials engineering and their applications in in-vitro (a, b) and in-vivo (c, d) RM 
approaches. (a) Functionalized synthetic substrates (2D surfaces) for stem cell expansion; (b) 
Functionalized hydrogels (3D environments) for recreating/manipulating stem cell niches; (c) 
Functionalized injectable biomaterials for sequestering GFs to promote endogenous tissue repair; (d) 
Functionalized nanocarriers for cell reprogramming (target delivery of genetic material to specific cells). 
Different databases (PepBank, Tree of Medicine, BDB) collating peptide sequences 
identified by phage display can be accessed free of charge, greatly contributing to data 
mining in this area. Currently, the biopanning data bank (BDB, at 
http://immunet.cn/bdb/) formerly known as MimoDB (33, 34) contains 26813 peptide 
sequences, showing that the use of phage display has exploded over recent decades. 
However, many of the discovered sequences have not been further analyzed and 
validated in-vitro or in-vivo to assess specificity, selectivity, and stability, nor have they 
had their structure optimized to be clinically useful. To facilitate the search of 
sequences with utility for RM applications, we have compiled in Table 1 a selected list 
of peptide sequences that bind to RM targets (i.e., ECM components of tissues, GFs, 
surface of stem and differentiated cells). These peptide ligands can be used to 
specifically localize imaging probes or drugs to damaged tissues for diagnostic 
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(immunohistochemistry, magnetic resonance imaging, positron emission tomography) 
and therapeutic (treating diseases) purposes; to deliver different biologics (e.g., GFs, 
oligonucleotides) to selected cell types for controlling their behavior (adhesion, 
survival, proliferation, migration, differentiation, angiogenesis); or to recruit local stem 
cells to sites of injury for stimulating tissue regeneration. The BiopanningDataSet ID 
was also included, when available, to facilitate the search in MDB, as well as the 
equilibrium dissociation constant (KD), which represents the binding affinity between 
the peptide ligand and the target, or the half inhibitory concentration (IC50) from 
competition binding assays. In addition, a follow-up was performed to identify 
transformative publications that have identified breakthrough sequences, inspired new 
experiments based on the original sequence, and contributed to their application and 
clinical development, with potential impact on RM. To discriminate such contributions, 
quantitative data on the number of citations for each publication were first gathered, 
and from these, original articles were selected (excluding reviews, editorials, book 
chapters) to perform the analysis. While carrying out this evaluation, we must bear in 
mind that, typically, there is a 1–3 year citation lag time for each article with impact, 
and certain sequences have been only recently published. Table 1 also summarizes the 
outcome of this analysis by identifying the number of publications that describe 
subsequent use of the original peptide sequence in diverse experimental studies, 
including in-vitro and in-vivo testing/characterization, and optimization/formulation 
toward their medical application. More details on this analysis can be found in Table S1 
(supplementary information). Many of the listed sequences have not resulted in any 
follow-up papers, mainly because they have been only recently discovered (since 
2008). One exception is compstatin, a cyclic tridecapeptide first identified by Sahu (35) 
from phage-display libraries, which binds to complement component 3 (C3), a protein 
of the immune system. An excellent review on the “clinical trajectory” of compstatin 
was provided by Ricklin and Lambris (36). This peptide has contributed significantly to 
the understanding of compstatin–C3 interactions and the generation of new 
therapeutics (complement inhibitors). Compstatin, and in particular POT-4 (Table S1), 
which has been commercialized by Potentia Pharmaceuticals, Inc., has entered phase I 
clinical trials for the treatment of age-related macular degeneration, and can be used 
for biomaterial functionalization to inhibit biomaterial-induced complement activation 
(37).  
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Table 1 Selected peptide sequences identified by phage display that bind to targets with relevance for biomaterials engineering in 
regenerative medicine applications 
Target 
Sequence 
(BiopanningDataSet ID) 
Ref.
a
 
(year) 
KD 
(µM) 
Designation/ 
Commercial name 
Follow-up
b 
Char
c
 Opt
d
 Appl
e
 
E
C
M
 c
o
m
p
o
n
e
n
ts
 
C
o
ll
a
g
e
n
 (
co
l)
 
Col I (rat) 
HVWMQAP (38) 
(2009) 
61±5 Coll I binding peptide - - 1  
Col I (human) 
(demineralized 
bone matrix) 
SWWGFWNGSAAPVWSR (39) 
(2008) 
<0.1 
(EC50) 
- - - 1  
Col II (bovine 
cartilage grafts) 
WYRGRL 
(486) 
(40) 
(2008) 
0.14 
(IC50) 
Col II binding peptide - - 5 
Col IV (human) 
KLWVLPK (41) 
(2010) 
0.114 
(IC50) 
- - - 5 
Hyaluronan (HA) 
GAHWQFNALTVR  
(756) 
(42) 
(2000) 
1.65 HA-binding peptide  
Pep-1 
1 2  23 
H
y
d
ro
x
y
a
p
a
ti
te
 
(H
A
P
) 
Crystalline HAP  
SVSVGMKPSPRP (43) 
(2008) 
14.1±3.8 - 3 - 1 
Synthetic HAP 
powder 
MLPHHGA, 
NPGFAQA 
(44) 
(2008) 
ND - - 1 2 
 
Single crystal 
HAP (100) 
NPYHPTIPQSVH 
(1342) 
(45) 
(2011) 
ND - - - 1 
C
e
ll
 s
u
rf
a
ce
, 
ti
ss
u
e
s 
a
n
d
 o
rg
a
n
e
ll
e
s 
D
if
fe
re
n
ti
a
te
d
 c
e
ll
s 
Cardiomyocytes  QPFTTSLTPPAR  
(1883) 
(46) 
(2011) 
ND - - - - 
Chondrocytes        
Mouse RLDPTSYLRTFW, 
HDSQLEALIKFM  
(2167) 
(47) 
(2013) 
ND - - - - 
Rabbit DWRVIIPPRPSA  
(1549) 
(48) 
(2011) 
ND CAP (chondrocyte 
affinity peptide) 
- - 1 
S
te
m
 c
e
ll
s 
Adipose 
derived 
       
Human adipose 
stem cells 
(ASCs) 
MLAGWIP  
(1576) 
(49) 
(2008) 
ND - - - - 
Mouse ASCs SWKYWFGE  
(1552),  
WLGEWLG  
(1576) 
(50) 
(2011) 
ND WAT7 - - - 
Bone marrow 
derived 
       
Human 
mesenchymal 
stem cells 
(MSCs) 
EPLQLKM  
(1941) 
(51) 
(2012) 
ND E7 (hBMMSC affinity 
peptide) 
- - 5 
Mouse MSCs NSMIAHNKTRMH 
 
(52) 
(2008)  
ND LAB (low affinity 
binding) peptide  
 
- - 1 
SGHQLLLNKMPN  ND HAB (high affinity 
binding) peptide 
- - 1 
Murine MSCs  STFTKSP  
(682) 
(26) 
(2004) 
ND BMHP (bone marrow 
homing peptide) 
2 - 4 
Rat MSCs  VTAMEPGQ  
(2294) 
(53) 
(2013) 
ND - - - 2 
Embryonic 
derived 
       
Human 
embryonic stem 
cells (ESCs) cell 
line X-01  
HGAAWGTRTGHV  (54) 
(2013) 
ND H166 - - - 
VGGEAWSSPTDL   H178  - - - 
Human ESCs  TVKHRPDALHPQ, 
LTTAPKLPKVTR  
(21) 
(2010) 
ND - - 1  - 
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a
 Reference/Year when the sequence was reported for the first time; 
b
 Number of research papers, from 
Web of Science Core Collection (Thomson Reuters), that describe subsequent use of the original 
sequence. Please see Table S1 for more details; 
c
 Characterization (determination of binding affinity, 
activity, stability, safety); 
d
 Optimization (rational, combinatorial and computational optimization to 
(655) 
Mouse ESCs  KHMHWHPPALNT  
(1262) 
(55) 
(2010) 
≈ 0.8 
(IC50) 
Seq2 peptide - - - 
Rhesus 
macaque ESCs 
APWHLSSQYSRT (56) 
(2010) 
≈ 0.5 
(IC50) 
- - - - 
Neuronal 
derived 
       
Mice neuronal 
precursor cells 
(NPCs)  
QTRFLLH,  
VPTQSSG 
(57) 
(2007) 
(0.3 µg) 
(IC50) 
- - - 1 
Murine 
neuronal stem 
cells (NSCs) 
KLPGWSG  
(2240) 
(58) 
(2013) 
ND KLPGWSG peptide 1 - - 
Rhesus monkey 
NSCs derived 
from ES cell line 
RS366.4 
HGEVPRFHAVHL  
(1516) 
(59) 
(2010) 
≈ 0.5 
(IC50) 
HGE peptide - - - 
Porcine skin 
TGSTQHQ  
(1847) 
(60) 
(2011) 
ND SPACE (skin 
permeating and cell 
entering) peptide 
- - 5 
Human Kaposi 
sarcoma KS1767 cell 
line 
(mitochondria/endop
lasmic reticulum 
fraction) 
YKWYYRGAA (61) 
(2012) 
ND - - - 1 
G
ro
w
th
 f
a
ct
o
rs
 Bone morphogenetic 
protein 2 (BMP-2)  
rhBMP-2  
TSPHVPY (62) 
(2005) 
0.037 - - - 2 
AGAWEAFSSLSGSRV (17) 
(2013) 
0.0014 
(EC50) 
BC-1 - - - 
Human recombinant 
basic fibroblast GF 
(rhbFGF) 
RTGQYK (63) 
(1993) 
0.122 - 1 
 
- 2 
 
Transforming GF β-1 
(TGFβ-1) 
HSNGLPL (62) 
(2005) 
ND - -  3  
C
e
ll
 r
e
ce
p
to
rs
 
Human recombinant 
stabilin-2 (4e5 
domain) 
RTLTVRK (64) 
(2011) 
ND S2P (stabilin-2 
peptide) 
- - - 
TGF-βR (human 
extracellular domain 
of TβRI and TβRII) 
LTGKNFPMFHRN (65) 
(2010) 
≈ 10 Pep1  - 1 - 
MHRMPSFLPTTL  
(1250) 
(65) 
(2010) 
≈ 10 Pep2 - 1 - 
rhTGF-β sRII/Fc 
GLLPVGRPDRNVWRWL 
KGQCDRFKGLPEW 
(66) 
(2002) 
≈ 1 - - - - 
O
th
e
r 
p
ro
te
in
s 
Complement 3 (C3) 
ICVVQDWGHHRCT (cyclic 
peptide) 
(35) 
(1996) 
ND Complement-
inhibiting peptide 
Compstatin 
 
10 21  19 
Vascular cell 
adhesion molecule 1 
(VCAM-1) 
VHSPNKK  
(354) 
 
(67) 
(2005) 
ND Cyclic VCAM-1 
peptide, known as VP 
(in-vitro screening) 
- 3 2 
VHPKQHR 
(353) 
(68) 
(2006) 
30 Linear VCAM-1 
internalizing peptide-
28 (VINP28) (in-vivo 
screening) 
- - 12 
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design new analogues with improved affinity/activity); 
e
 Application (biomaterials engineering for 
targeted binding/delivery, conjugation with imaging agents for targeted detection, mechanistic studies 
and therapeutics); ND: not determined. 
In some cases, more than one sequence is identified for the same target. For example, 
when screening hydroxyapatite (HAP) materials, different powder particles, of various 
sizes and morphologies, used for the selection may explain the observed differences. 
Ideally, the selection should be performed using a material with specific morphology, 
crystallography, and stereochemistry. As described previously, several phage clones 
are selected in a first screening, and the relative affinity tends to increase with an 
increasing number of panning cycles. After this first screening, isolated clones are 
analyzed by ELISA, for example, for cross reactivity and binding ability. Sequences with 
varied affinities (high, intermediate, or low binding constants) can be obtained, thus 
allowing the engineering of binding affinity and specificity. Furthermore, by comparing 
the sequences obtained by phage display with the ones derived from natural proteins 
known to bind to the same targets, differences in the amino acid composition and 
sequence are also observed. For example, Mummert et al. (42) found a 12-mer peptide 
that binds to hyaluronan (HA, Table 1) using phage display. This peptide sequence does 
not show significant (>25%) similarity with the HA-binding motifs found in hyaladherins 
(CD44, RHAMM, or link protein) (69), nor does it shows a consensus domain, known to 
be identical among these three HA-binding proteins (69). Nonetheless, the authors 
showed that the phage-identified peptide specifically binds to HA free in solution or 
bound to a substrate, and also to HA expressed on the cell surface, and that prevented 
the binding of HA to leukocytes and their attachment to HA coated surfaces. In 
addition, this sequence has been validated in numerous subsequent studies (Table S1).  
 
Biomaterials functionalized with peptide ligands identified by phage display as in-
vitro cell culture models  
The isolation and culture of human stem cells in-vitro have largely contributed to 
important advances in fundamental cell biology and cell therapies, by understanding 
the molecular mechanisms involved in the processes by which stem cells undergo self-
renewal or differentiation (70). Recent discoveries have shown novel mechanisms by 
which stem cell fate is regulated (71-73), but continued research in the molecular 
biology of stem cells will boost their application in RM. A challenge in cell-based 
therapies is to find adequate sources of stem cells and the need for maintaining them 
undifferentiated during in-vitro expansion. Thus, there is an urgent need to develop 
precise and reproducible culturing systems able to control the behavior of human stem 
cells in-vitro. In addition, for cell therapies in humans, an essential requirement is to 
avoid the exposure of stem cells to animal-derived components during culture. 
Advances in biomaterials engineering has enabled the development of in-vitro culture 
platforms for cell expansion, and also for the differentiation of stem cells into specific 
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lineages. In-vivo, cells receive signals from the ECM and other cells through specialized 
transmembrane proteins that bind to components of the ECM and receptors of 
neighboring cells. One potential approach to mimic these interactions and guide cell 
growth or differentiation in-vitro is the use of biomaterials based on peptide 
sequences that bind to those cell receptors. Phage display has been applied to probe 
the surface of different stem cells, including adipose progenitor cells (49, 50), bone 
marrow-derived mesenchymal stem cells (MSCs) (26, 51-53, 74), and embryonic stem 
cells (ESCs) (21, 54-56) (Table 1). The latter are of special interest, considering their 
differentiation pluripotency. Peptide ligands for stem cell receptors can then be 
broadly used in cell culture and differentiation (immobilized on 2D surfaces or 3D 
hydrogels), namely, as probes for detection of specific stem cell populations during 
isolation procedures or to ascertain the role of proteins for stem cell differentiation. 
 
2D substrates for the controlled expansion (and/or differentiation) of (stem) cells 
Kiessling and collaborators (21) used a peptide sequence identified by phage display 
(binding receptors on human embryonal carcinoma, Table 1) for culturing ESCs. Using 
self-assembled monolayers (SAMs) for displaying bound peptide ligands on a synthetic 
surface (Figure 2-a1), they showed that these chemically defined functional substrates 
supported the undifferentiated proliferation of pluripotent cells (Figure 2-a2). These 
cells are capable of replicating indefinitely and generate all human cell types, offering a 
useful resource for both research and RM. Thus, a surface with a well-defined 
composition could eliminate the problem associated with the use of animal-derived 
proteins, which suffer from batch-to-batch variability, and increase the predictability of 
culturing cells in-vitro. 
Similarly, MSCs cultured on peptide SAMs containing BMHP1 (Table 1, Figure 2-b1) in 
maintenance medium (DMEM) or osteogenic differentiation medium (ODM) were able 
to produce higher amounts of calcium than when cultured on bare substrates (Figure 
2-b2, b3), demonstrating that BMHP1 can enhance cell mineralization. It was also 
shown that the amount of calcium deposition was dependent on the peptide density 
(Figure 2-b3).  
These studies showed the utility of the identified peptides for elucidating cell–matrix 
interactions in 2D. This information could be translated for the functionalization of 3D 
biomaterials to control cell behavior.  
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Figure 2. 2D biomaterials (surfaces) functionalized with peptide sequences identified by phage display 
for in-vitro cell culture (proliferation and differentiation). (a) Synthetic surfaces of SAMs displaying 
phage-derived peptides that bind to the surface of human ESCs support their undifferentiated growth; 
(a1) SAMs composed of perfluorinated alkanethiols (ATs) containing different ratios of peptide-AT and 
glucamine-AT (non-adherent for cells) to obtain surface arrays of peptides with different densities; (a2) 
Human ESCs (hESCs) proliferating on peptide-AT SAMs maintain expression of markers of pluripotency 
(Oct4 and SSEA4). Adapted with permission from ref. (21). Copyright 2010 American Chemical Society. 
(b) BMHP1 immobilized on 2D surfaces induce the osteogenic differentiation of MSCs; (b1) Linear and 
cyclic BMHP1 (cBMHP1) were conjugated to maleimide-functionalized quartz substrates via a cysteine 
residue inserted in the N-terminal; (b2) Low-magnification (200×) inverted microscopy images of Alizarin 
Red S (forms a bright red complex with calcium) staining on MSCs cultured on bare and peptide-
functionalized surfaces in DMEM (top panel) and ODM (bottom panel) for 7 days (insets show 
macroscopic images); (b3) Colorimetric quantification of calcium deposition by cells cultured in DMEM 
(left) and ODM (right). Adapted from ref. (75) with permission of The Royal Society of Chemistry. 
Growth factors (GFs) are involved in numerous cellular processes, such as cell growth, 
differentiation, and migration. TGF-β is able to both positively and negatively affect 
inflammation and wound healing. Thus, several studies have been performed towards 
the identification of peptide ligands with selectivity and affinity to this GF and its 
receptors, aiming to understand their interactions and thus develop new strategies to 
tune their signaling capacity. 
The regenerative potential of surfaces functionalized with TGF-β1-binding peptide 
(Table 1) through azide-terminated SAMs and microcontact printing, and pre-loaded 
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with TGF-β1, was evaluated by culturing human articular chondrocytes (hACs) on the 
material (76). After 7 days of culture, more cells were observed on the peptide-
functionalized surfaces than on the bare azide SAMs. Chondrocytes cultured in the 
absence of TGF-β1 were found to be more extended, resembling the typical 
morphology of fibroblasts, while those cultured in presence of TGF-β1, exhibited a 
round polygonal shape, representative of chondrocyte phenotype. In addition, 
glycosaminoglycan (GAG) analysis revealed higher levels of GAGs in lysates of hACs 
cultured on peptide-functionalized surfaces with bound TGF-β1 compared to hACs 
cultured on glass and with the GF free in the medium, and for cultures on peptide-
functionalized surfaces without TGF-β1. 
Using phage display, two peptides that bind specifically to the TGF-β receptor II (TβRII) 
(Table 1) have been identified (66). These peptides can mimic or block distinct 
functions of TGF-βI, and can be used to regulate these different functions, separately 
or in concert, which are important for vascular therapy. The group of Kiessling also 
used phage display to identify peptide ligands specific for TGF-β receptors I and II (65) 
(Table 1). They showed that the identified peptides bind to the receptors on a region 
different from the binding site used by TGF-β, thus not interfering with TGF-β signaling. 
Therefore, these ligands can be applied as tool to examine the diverse cellular 
functions of TGF-β, as well as to promote the identification of potential therapeutics. 
Indeed, in later work, Kiessling and co-workers employed SAMs to present the 
previously identified peptide sequences, which interact with both TGF-β receptors 
(TβRI-ED and TβRII-ED), to provide localized and defined spatial signaling to cells (77). 
As a proof of concept, they used NMuMG mouse mammary gland cells to investigate 
the attachment of cells expressing TGF-β receptors to the surfaces displaying the TβR-
binding peptides. The cells bound to SAMs presenting either peptide (even at low 
peptide densities, 4%), but not to the bare surfaces. They further demonstrated that 
the functionalized surfaces activated Smad2/3 nuclear translocation (a hallmark of 
TGF-β signaling).  
These studies demonstrate the power of phage display to generate peptides that can 
be used to regulate signaling pathways that lead to specific cell outcomes. Strategies 
to control the beneficial roles of signaling pathways would be valuable for applications 
in RM. 
 
3D hydrogels for recreating specific (stem) cell or tissue environments 
Molecular design of biomaterials offers the opportunity to incorporate peptide ligands 
that can be recognized by specific cell receptors or enzymes, and to control their 
spatial and temporal availability for triggering regenerative events. The incorporation 
of peptide sequences identified by phage display into molecularly-designed 
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biomaterials, and in particular, self-assembling peptide biomaterials, has been 
reported by several groups.  
Being the major inorganic constituent of bone and teeth, HAP has received great 
attention as a target for phage display experiments. For example, the Sarikaya group 
identified a HAP-binding peptide (Table 1) (44), which was then incorporated into a 
peptide hydrogel capable of directing the mineralization of HAP (78) (Figure 3a). Other 
studies describing peptides with preferential adsorption to HAP-based materials have 
also been reported (45, 79, 80) (Table 1). Peptides with binding affinity to different 
apatite substrates can be used to direct the growth of HAP on biomaterials surfaces 
(81), or to improve the functional properties of HAP-based scaffolds, and thus enhance 
bone regeneration. 
The Stupp laboratory designed self-assembling peptides, known as peptide 
amphiphiles (PAs), for RM applications. Of particular interest for the purpose of this 
review, are PAs designed to bind GFs using peptide sequences derived by phage 
display. They first reported a novel class of reverse PAs to enable the creation of 
peptide assemblies with free N-terminal, which were not possible to obtain through 
the original design. They were able to apply this new methodology to synthesize PAs 
incorporating peptide sequences, derived via phage display and requiring a free N-
terminus, that bind GFs, BMP-2, and TGF-β (Table 1) (62), all involved in stem cell 
differentiation. These PA molecules are known to form nanofibers by self-assembly 
(Figure 3-b2), which at sufficiently high concentration, is accompanied by gelation 
(Figure 3-b1). By permitting the direct binding of the GF to the PA nanofiber, gels 
containing BMP-2 bound to PA allowed prolonged GF retention (Figure 3-b3). When in 
solution, the BMP-2-bound PA nanofibers induced the differentiation of C2C12 pre-
myoblast cells into osteoblasts, as detected by an increased number of alkaline 
phosphatase (ALP, marker for osteoblast differentiation)-positive cells (Figure 3-b4). 
The BMHP motif was used by Gelain and co-workers (58, 82-86) to functionalize self-
assembling peptide scaffolds for culturing and controlling neural stem cell (NSC) 
behavior for nervous tissue regeneration. In their pioneering work (83), they used 
BMHP-functionalized self-assembling peptide hydrogel scaffolds for 3D culture of adult 
mouse NSCs. In differentiation assays, the scaffolds containing BMPH motifs (BMHP1 
and BMHP2, Figure 3-c3,c4) showed β-tubulin
+
 and nestin
+
 cells comparable with those 
cultured on Matrigel (Figure 3-c1). β-Tubulin
+
 cells on BMPH scaffolds also showed 
increased branching when compared with non-functionalized scaffolds (Figure 3-c2). 
These results demonstrate the ability of these synthetic peptide nanofiber scaffolds to 
be functionalized with different peptide motifs for the controlled 3D culture of diverse 
cell types.  
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 Figure 3. 3D biomaterials (hydrogels) functionalized with peptide sequences identified by phage 
display for in-vitro cell culture (proliferation and differentiation). (a) Self-assembled peptide hydrogels 
functionalized with HAP-binding peptides for periodontal regeneration; (a1) Schematic illustration of the 
peptide self-assembly and hydrogel formation; (a2) Fluorescence microscopy image of a live/dead assay 
on cementoblast cells encapsulated within self-assembling peptide gels showing viable cells; (a3) 
Scanning electron microscopy (SEM) image of the peptide gel showing the deposition of calcium-
phosphate mineral by cementoblasts, as confirmed by the corresponding EDXS (inset). Reprinted and 
adapted from ref. (78). Copyright 2010 with permission from Elsevier. (b) BMP-2-binding PA (BMP2b-PA) 
nanofibers induced osteoblast differentiation of a myoblast cell line (C2C12) in vitro; (b1) Photographs 
of PA-based gels (D-BMP2b-PA: obtained by mixing equal ratios of BMP2b-PA with diluent PA at the 
same concentration); (b2) SEM micrographs of PA gels showing the network of filamentous 
nanostructures; (b3) In vitro release of BMP-2 from PA gels, with or without BMP-2-binding PA, in 
comparison to collagen sponges pre-loaded with BMP-2 up to 28 days; (b4) Optical micrographs of 
C2C12 cells stained for the detection of ALP on day 3 of culture in growth medium supplemented with 
treatment media containing 50 ng mL
-1
 of BMP-2 with heparin or PAs at different concentrations. 
Adapted from (87). Copyright© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. (c) NSC 
differentiation on 3D peptide nanofiber gel scaffolds functionalized with bone marrow binding peptides, 
BMHPs; (c1-c4) Inverted fluorescence microscopy images of differentiating adult mouse NSCs cultured in 
vitro during 7 days on: (c1) 1% Matrigel (positive control), (c2) non-functionalized RADA16 peptide gel 
(negative control), (c3) RADA16-BMHP1, and (c4) RADA16-BMHP2, stained for cell nuclei (blue), β-
tubulin
+
 (red) for neurons, and nestin
+
 (green) for neural progenitors (green). Adapted with permission 
from ref. (83). Copyright 2006 PlosOne. 
Chemically crosslinked hydrogels, such as those composed of poly(ethylene glycol) 
(PEG), have been functionalized with different peptide ligands to culture cells in 3D. 
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The Anseth group (88) functionalized PEG hydrogels with a basic fibroblast growth 
factor (bFGF)-binding peptide, previously selected by phage display (63), to control GF 
retention and sustained release for applications in GF-induced regeneration. To 
enhance the affinity of the bound ligand for diffusible proteins (e.g. GFs) within the 
hydrogel, they synthesized tri-functional peptides and examined how the molecular 
structure of the affinity peptides affected their accessibility and binding using Forster 
resonance energy transfer. They then showed that the optimal functionalization 
strategy allowed the sustained release of bioactive bFGF able to induce the in-vitro 
differentiation of the PC12 pheochromocytoma cell line. This affinity hydrogel could be 
manipulated for GF retention, or delivery, and be easily applied in distinct RM 
approaches, such as controlled stem cell differentiation in-vitro, or GF-mediated 
wound healing in-vivo.  
 
Implantable biomaterials functionalized with peptide ligands identified by phage 
display for promoting endogenous tissue repair in-vivo  
Tissue regeneration in-vivo can be enhanced by promoting the recruitment and 
localization of stem cells into injured tissues and/or stimulating the function and 
differentiation of local stem cells. This can be achieved by manipulating the properties 
of the niche (e.g. promote angiogenesis or de-novo niches) or through the delivery of 
active molecular regulators, directly or combined with a biomaterial, or by using 
biomaterial sequestering GFs. 
Stem cell homing 
Using polycaprolactone (PCL, a FDA-approved polymer for medical applications) 
electrospun meshes conjugated with phage-derived peptide (E7, Table 1) with affinity 
for human bone marrow-derived MSCs (hBMMSCs), Shao and co-workers showed 
improved recruitment of MSCs in-vivo after implantation in full-thickness articular 
osteochondral defects in a rat knee (51). Immunofluorescence staining of harvested 
implants (Figure 4-a) showed that cells on the E7-conjugated PCL meshes were mostly 
positive for CD44, CD90, and CD105 (MSCs surface markers), indicating that the 
functionalized scaffold could selectively recruit and retain MSC-like cells from the bone 
marrow. In contrast, cells in the PCL meshes conjugated with the cell adhesive peptide 
RGD (with no cell specificity, control) showed lower levels of MSCs surface markers. 
CD68 staining was also used to assess the inflammatory response. Results from 
immunofluorescence staining showed that there was a high proportion of 
inflammatory cells in the RGD-conjugated PCL meshes, while CD68
+
 cells were scarce in 
the E7-conjugated scaffold, suggesting only a minor inflammatory response. For the 
bare PCL meshes, only few cells could be detected into the mesh, due to the 
unfavorable cell adhesion properties of PCL. The E7 peptide could be further applied 
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for functionalizing other biomaterials for effective MSC-homing in stem cell-based 
tissue repair strategies. 
Controlled release of growth factors (GFs) 
TGF-β1 is known to play a critical role in the development, growth, maintenance and 
repair of articular cartilage. To this end, the Stupp group designed self-assembled 
peptide nanofibers for cartilage regeneration, using a peptide sequence derived by 
phage display with binding affinity for TGF-β1 (Table 1) (89). When implanted into a 
full-thickness chondral defect in a rabbit model (Figure 4-b1), these self-assembled gels 
were shown to support the regeneration of articular cartilage (Figure 4-b2, b3) with or 
without the supplementation of TGF-β1, as detected by formation of hyaline-like tissue 
(GAGs and collagen II staining, Figure 4-b3) within the defect space. 
To promote bone healing, Hamilton et al. (17) developed a novel strategy to deliver 
osteogenic GFs, such as BMP-2, in a collagen biomaterial carrier. This carrier contained 
a bifunctional peptide (BC-1) that displayed BMP-2 and collagen-binding domains, both 
identified by phage display (Table 1). This strategy allowed the simultaneous binding of 
GFs directly to an implantable biomaterial, without the requirement for any 
conjugation steps, thus allowing the controlled delivery of GFs at the implantation site. 
To test the ability of this system to promote bone formation in-vivo, the authors 
injected BMP-2 within a collagen gel, containing or lacking BC-1, into the subcutaneous 
regions of Sprague Dawley rats (rat ectopic bone formation model). Histological 
analysis and evaluation of the explants showed significantly higher osteogenic cellular 
activity, bone area formed, and bone maturity in the presence of BC-1 (Figure 4-c1, 
c2).  
Page 20 of 38
ACS Paragon Plus Environment
ACS Chemical Biology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 4. The application of phage-derived peptides for in-vivo tissue regeneration. (a) In-vivo stem cell 
homing by PCL electrospun meshes functionalized with E7 peptide with specific affinity for MSCs; (a1) 
Confocal microscopy images of peptide-conjugated PCL electrospun meshes harvested 7 days after 
implantation in full-thickness articular osteochondral defects in rats and stained by immunofluorescence 
for specific MSC (CD44, CD90, CD105) and inflammatory (CD68) markers (green: FITC, blue: 
Hoeschst33258, red: CD44/CD90/CD105/CD68 counterstained with Cy3 & Cy5). Reprinted and adapted 
from ref. (51). Copyright 2012 with permission from Elsevier. (b) PA molecules displaying binding 
epitopes for TGFβ-1 support the regeneration of full thickness chondral defects in articular cartilage; 
(b1) Surgical and implantation procedure showing: (b1.1) full thickness articular cartilage defects made 
with a microcurette in rabbit trochlea; (b1.2) Microfracture holes through the subchondral bone using a 
microawl to promote bleeding into the defect; (b1.3) Injected PA gel in the defect (arrow); (b1.4) PA gel 
labeled with a fluorescent dye contained within the cartilage defects after injection. (b2) Images of 
articular cartilage defects after 12 weeks of implantation with: (b2.1) 100 ng∕mL TGF-β1; (b2.2) Filler PA 
+ 100TGF; (b2.3) 10%TGFBPA +100TGF, (b2.4) 10%TGFBPA alone. (b3) Microscopy images of tissue 
sections of articular cartilage defects obtained from histological and immunohistochemical analysis and 
stained for GAGs using safranin-O (left panel) and type II collagen (right panel) 12 weeks after treatment 
with: (b3.1, b3.2) 100 ng∕mL TGF-β1; (b3.3, b3.4) filler PA +100TGF; (b3.5, b3.6) 10%TGFBPA +100TGF; 
(b3.7, b3.8) 10%TGFBPA alone. Reprinted with permission from (89). Copyright (2010) Proceedings of 
the National Academy of Sciences of the United States of America. (c) An injectable collagen gel 
containing a bifunctional peptide (BC-1) with affinity for collagen and BMP-2 enhances retention of 
BMP-2 and increases ectopic bone formation; (c1) Osteogenic cellular activity, bone area and bone 
maturity scored from H&E slides (c2) and by two observers; (c2) Histology images (H&E staining) from 
the rat ectopic model; (c2.1) 2 µg BMP-2 in 1.5% collagen gel; (c2.2) 2 µg BMP-2 with 50-fold molar 
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excess of BC-1 in 1.5% collagen gel. (b – bone zones; c – collagen zones; cells are stained blue). Adapted 
with permission from ref. (17). Copyright 2010 PlosOne. 
Degenerative joint diseases, such as osteoarthritis (OA), are characterized by 
progressive cartilage matrix degradation. Targeted therapies for damaged articular 
cartilage can offer the opportunity for localization of bioactive proteins, such as GFs, 
that can enhance the synthesis of a more hyaline-type cartilage. Towards this 
challenge, Hubbell’s group described the synthesis and functionalization of 
nanoparticles for the release and retention of drugs inside articular cartilage through 
the identification of a peptide specific for the principal component of the cartilage 
matrix (collagen II α1, Table 1) (40). After intra-articular injection in a mouse model, 
conjugation of the peptide to nanoparticles led to higher retention of the 
nanoparticles within the ECM of articular cartilage (72-fold increase after 48 h) when 
compared to nanoparticles functionalized with a non-targeted (control) peptide. Such 
an approach could be used to deliver and localize specific GFs for cartilage repair. 
 
Nanobiomaterial carriers functionalized with peptide ligands identified by phage 
display for genetic manipulation of cells in-vitro and in-vivo 
The field of gene therapy for tissue repair and regeneration would benefit considerably 
from the isolation of peptides that can target endocytosing receptors on specific cells 
(90). Internalization of gene delivery systems is a prerequisite for efficient transgene 
expression. Peptides that can be internalized by cells are likely to be useful for 
nonviral-mediated gene delivery, where some current systems do not have the ability 
to enter the cells (e.g. polycation-DNA complexes). Gene therapy vectors could be 
modified with specific peptide ligands and delivered intravenously to transfect only 
specific cells, thus improving their efficacy and reducing the toxicity of the process. 
Therefore, many research groups have attempted to select cell-binding and cell-
penetrating peptides (“homing peptides”) using phage display for targeting specific cell 
types (91, 92).  
Targeted gene therapy 
The use of phage display to identify cell-selective and cell-entry peptides as gene 
therapy vectors was first reported by Barry and colleagues in 1996 (92). They displayed 
12- and 20-mer peptide libraries on pIII protein of fdTET phage and, by screening the 
libraries on mammalian cells, isolated cell-binding peptides. This was the first 
demonstration that cell-selective peptides could be identified by panning peptide 
phage libraries on cells, without prior information of the target receptors. However, in 
this pioneering work, they did not demonstrate the delivery of functional genes to the 
nucleus of specific mammalian cells. 
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In attempt to develop in-situ gene therapy, Schmidt el al. (57) identified peptide 
ligands (Table 1) that selectively bound to mouse NPCs from phage display peptide 
libraries. They subsequently conjugated the identified peptides to wild-type capsid and 
capsid-mutated adenovirus (Ad) vectors and tested their targeting potential in-vitro 
and in-vivo, respectively. Peptides were shown to mediate Ad binding and infection of 
NPCs in-vitro, and selective transduction of NPCs in the brain of adult C57BL/6 mice, as 
shown by the presence of nestin (Figure 5-a1), a NPC-specific marker, co-localized with 
green fluorescent protein (GFP) (Figure 5-a2). Injection of a non-specific peptide failed 
to transduce cells in the dentate gyrus, as seen by the absence of GFP expression 
(Figure 5-a3), while injection of wild-type capsid AdGFP resulted in transduction of 
non-NPCs, such as astrocytes and neurons (Figure 5-a4).  
Using a non-viral vector (poly(amido)amine (PAMAM) dendrimers) functionalized with 
bone-targeting peptides, identified by phage display and having high (HAB) and low 
(LAB) affinity binding to mouse MSCs, Santos and co-workers (93) were able to 
promote the uptake of plasmid DNA (pDNA) by rat MSCs (rMSCs). HAB peptide-
functionalized dendrimers led to increased accumulation of pDNA inside cells (Figure 
5-b1). In addition, the presence of HAB bone-targeting peptides on the dendrimer 
surface led to higher transfection levels than those obtained with native dendrimers, 
measured by luciferase (Luc) gene expression (Figure 5-b2). Similarly, Ma and 
colleagues (53) used a rMSC-homing peptide, identified by phage display (Table 1), to 
improve the targeting capability of protamine/DNA lipoplex (LPD) liposomes to rMSCs 
for the delivery of Sleeping Beauty (SB) transposon plasmid. They also incorporated 
the positively charged nuclear localization signal (NLS) peptide to promote 
translocation of gene materials into the nucleus. By combining rMSC-targeting ability 
and NLS peptide into LPD liposomes, the transfection efficiency was improved, in 
comparison to control peptides (randomly selected), by enhancing the receptor-
mediated endocytosis of LPD liposomes and their accumulation in the nucleus. They 
showed that the SB transposon and targeting LPD system did not result in cell toxicity, 
and did not promote osteogenic differentiation, suggesting the potential of this system 
for effective nonviral gene delivery in stem cell therapy. 
By panning on porcine skin, Hsu and Mitragotri (60) identified a peptide by phage 
display, named as skin permeating and cell entering (SPACE) peptide, to enable the 
diffusion of macromolecules across the stratum corneum into the epidermis and 
dermis. The peptide also showed ability to translocate the membrane of skin cells, 
such as keratinocytes, fibroblasts, and endothelial cells (Figure 5-c1). The efficacy of 
the peptide to carry and release small interfering RNA (siRNA) for GFP (Figure 5-c2.1) 
and IL-10 was tested in-vitro and in-vivo (Figure 5-c2.2), respectively. Peptide 
conjugation with siRNA led to enhanced cell penetration and absorption into the skin, 
and knockdown of corresponding protein targets. On the contrary, however, no 
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substantial knockdown was obtained with only siRNA or SPACE or using control siRNA 
conjugated with SPACE or a control peptide.  
 
Figure 5. Cell-targeting gene delivery for selective and more efficient in-vitro and in-vivo gene therapy. 
(a) Selective transduction of NPCs in adult C57BL/6 mouse brain by capsid-mutated AdGFPL.VPTQSSG 
vector. Fluorescence-activated laser scanning microscopy images of brain sections analyzed by 
immunohistochemistry after injection of: (a1, a2) PEGylated AdGFPL.VPTQSSG, (a3) AdGFPL.HTFEPGV, 
(a4) AdGFP into the dentate gyrus of adult mice. Nestin (red fluorescence, a1) and merge (yellow a2); 
Abbreviations: AdGFP, adenoviral vector that expresses GFP; AdGFPL, adenoviral vector that expresses 
GFP-Luc; VPTQSSG, NPC-specific binding peptide; HTFEPGV, unspecific peptide; gcl, granular cell layer;. 
Reprinted and adapted from ref. (57). Copyright 2007 with permission from John Wiley and Sons. (b) 
Targeted gene delivery using PAMAM dendrimers functionalized with MSCs binding peptides; (b1) 
Fluorescence microscopy images showing intracellular localization of (RITC)-labeled pDNA (red) in MSCs 
transfected with native dendrimers (unconjugated, G5) and dendrimers conjugated with 4 peptide arms 
[G5-(HAB)4, G5-(LAB)4] as vectors. The endosomal-lysosomal system was stained with LysoSensor Green 
DND-189 (green), and the nucleus with DAPI (blue); (b2) Luc gene expression obtained with dendrimers 
(native and conjugated with 2, 4 and 8 HAB peptide arms) with and without pre-saturation of cell 
receptors by HAB peptide (0.1 mM). Reprinted with permission from (93). Copyright (2010) American 
Chemical Society. (c) Delivery of siRNA into the skin and cells using SPACE peptide; (c1) Confocal 
microscopy images of human umbilical vein endothelial cells (HUVECs) (nuclei stained in blue) treated 
with: (c1.1) PBS (control), (c1.2) FITC-labeled SPACE peptide for 24 h; (c2) Delivery of siRNA in vitro and 
in vivo; (c2.1) Percentage of knockdown of GFP in GFP-expressing endothelial cells; (c2.2) Percentage of 
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knockdown of interleukin-10 (IL-10) in mice after 24 h of treatment. Reprinted with permission from 
(60). Copyright (2011) Proceedings of the National Academy of Sciences of the United States of America. 
Using a cartilage affinity peptide (CAP, Table 1) conjugated with polyethyleneimine 
(PEI) for DNA complexation (CAP-PEI/DNA) in in-vivo cartilage-targeted gene delivery, 
Pi et al. (48) showed that the CAP-functionalized vector led to a nine-fold higher 
transfection efficiency in cartilage than the scrambled peptide-conjugated vector. 
However, no statistical difference in the transfection efficiency was observed in the 
synovium between the vectors modified with targeted (CAP) and control (scrambled) 
peptide. 
The identification of peptide ligands binding to receptors in organelles of mammalian 
cells (Table 1) was recently reported (61). When chemically fused to penetratin, the 
identified peptide was internalized and localized in the mitochondria, promoting cell 
death. This study demonstrated the further utility of phage display for subcellular 
targeted drug delivery. Advances in targeted intracellular delivery selectivity also has 
implications for RM, namely, in RNA interference (RNAi)-based anabolic therapies, 
such as the delivery of osteogenic siRNAs specifically to osteoblasts (bone cells), aimed 
at promoting bone formation (94, 95). 
 
Imaging probes functionalized with peptide ligands identified by phage display for 
targeted imaging of cells and tissues in-vitro and in-vivo  
Clinical imaging is an essential tool in RM. First, it is important to characterize the 
status of the damaged/diseased tissue for pre-treatment planning, and second, it is 
necessary to evaluate the risks and efficacy of the therapy (post-transplant 
assessment) (96). 
Injured and regenerating host environment  
The environment in injured or diseased tissues is not favorable for transplanted cells. 
Some tissues produce scars (e.g. fibrotic scar, glial scar) after injury, and this scarring 
process prevents engraftment of stem cells with the neighboring tissues. Additional 
factors that contribute for a hostile condition in damaged tissues include the presence 
of inflammatory cytokines and limited oxygen and nutrient delivery. Aging of the stem 
cell niche and corresponding alteration of the acellular components can cause loss of 
stem cell functionality. Thus, imaging of the niche properties, including tissue 
architecture (structural integrity/morphological alterations), and molecular and 
cellular composition (e.g. ECM, GFs, cell populations), could be beneficial for ensuring 
that cells are hosted in a healthy environment (non-necrotic tissues). Peptides can be 
combined with fluorophores or radioisotopes for the development of new probes (97), 
as they provide numerous benefits over antibodies; they have higher stability and 
lower immunogenicity, diffuse faster (owing to their small size allowing better tissue 
penetration), and are easier to synthesize. 
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Peptide sequences binding to major components of the ECM of tissues, such as 
collagen and HA (Table 1), have been identified by phage display. These sequences 
have been further developed into molecular probes to detect these macromolecules in 
different tissues (e.g. pericardium, skin).  
HA plays a central role in the wound healing process, and influences stem cell behavior 
(98, 99). The HA-binding peptide, described as Pep-1 in the literature, has been 
biotinylated for identification of HA in the skin (42).   
To improve the affinity of a phage-derived collagen-binding peptide for detecting 
collagen I in tissues, and to improve contrast/detection, the Meijer group proposed a 
new approach to display phage-derived peptides on dendritic architectures (18, 38). In 
this system, a dendron mimics the pentavalent head of the phage (Figure 6-a1). The 
system was then tested using a collagen-specific 7-mer peptide against collagen type I 
from rat tails (38). Pentavalent display of collagen-binding peptides on dendrimer 
wedges enhanced affinity for collagen by 100-fold when compared with the 
monovalent peptide (38), allowing selective staining of collagen in tissues containing 
collagen arranged in different levels of organization (fibrils, fibers, fiber bundles). Using 
0.6 μM fluorescein-labeled pentameric peptide on pig parietal pericardium, a highly 
defined fibrous network with fibers of 2 μm in thickness was observed (Figure 6-a2). 
This result demonstrate that the identified peptide, derived from rat collagen, also 
binds to collagen of different species. The monovalent form of the collagen binding 
peptide at the same concentration (Figure 6-a3) did not allow collagen detection. 
Comparable collagen fibrillar structures were visualized as for the pentameric peptide 
when using 60 μM of the monovalent peptide, but the intensity of background 
fluorescence was higher (Figure 6-a4). A naturally occurring collagen binding protein 
(CNA35) was used as a comparison with the fluorescein-labeled pentavalent peptide. 
Both probes allowed visualization of collagen fibers with the same orientation, but the 
pentameric peptide led to a more specific stain when compared to CNA35 (Figure 6-
a5-a7).  
Optical and nuclear imaging agents could be coupled to ECM-binding peptides to allow 
clinical imaging and characterize organ/tissue morphology (e.g. degraded matrix) 
before and after the therapies (matrix formation as a result of regeneration).  
Lee and collaborators reported the results of panning against stabilin-2 (64) (Table 1), 
known to be produced by activated macrophages and also strongly expressed in 
smooth muscle cells and endothelial cells of atherosclerotic lesions. The identified 
peptide sequence was found to bind specifically to stabilin-2 and localize to 
atherosclerotic plaques in-vivo. In addition, the peptide was conjugated with 
fluorescently tagged glycol chitosan nanoparticles and administered to apolipoprotein 
E-deficient mice through direct injection into the left ventricles. The peptide-
conjugated nanoparticles were found to accumulate in the atherosclerotic lesions, 
while control nanoparticles were not visible. These studies revealed peptide ligands 
that can be used for selective molecular imaging of atherosclerosis. 
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Phage display-derived vascular adhesion molecule 1 (VCAM-1)-specific peptide has 
allowed targeted imaging of activated endothelium under inflammatory conditions by 
fluorescence imaging and magnetic resonance imaging (MRI, Figure 6b), and has 
enabled the visualization of structural abnormalities in the aortic wall (67). Similar 
probes could be developed against pro-inflammatory cytokines implicated in tissue 
injury (e.g. tumor necrosis factor α (TNF-α); interleukin 1-β (IL-1β)) to characterize 
tissue functionality and delineate the feasibility of the cell therapy. 
Phage-derived peptides would be also useful to measure regeneration outcomes, such 
as angiogenesis and formation of new tissue. For example, angiogenic vasculature has 
been assessed by imaging the binding of RGD-containing peptides conjugated to PET 
imaging agents to specific integrins on the cell surface (100). Using the above-
described probes, the production and structure of tissue-specific ECM components 
(e.g. collagen II in cartilage or HAP in bone or tooth) could be visualized independently 
and non-invasively through different imaging modes. Similarly, the functionality of 
newly-formed tissue could be detected by assessing the presence of specific cell 
populations using ligands for phenotype-specific markers. The discovery of novel 
peptide ligands for the development of molecular imaging probes with enhanced 
specificity for detecting constant changes in the environment of damaged and 
regenerating tissues would greatly benefit cell-based therapies.  
 
Cell labeling/tracking 
Tracking the distribution, function, and fate of transplanted cells using noninvasive 
imaging is an important goal in RM. The ability to assess cell localization, viability, 
growth, differentiation, and engraftment in the host would be extremely valuable. 
However, cells administered into humans cannot be tracked unless they are first 
labeled in-vitro. Cells can be labeled directly, using chemical agents, or indirectly, by 
inclusion of reporter genes. Cell labeling methods should be specific, nontoxic, and 
stable (i.e. label agents should remain in the target cells for suitable periods of time to 
allow correlation with cell numbers).  
Several cell-binding peptides have been identified, with the isolation of stem-cell 
binding peptides being of particular utility for RM applications (100) (Table 1). These 
peptides can be exploited for cell labeling/imaging and isolation purposes. For 
example, Ma’s group (54-56, 59) used phage-derived cell-binding peptides conjugated 
with quantum dots (QDs, light emitting agents) to specifically label ESCs. By panning on 
rhesus macaque ESCs, they identified the sequence, APWHLSSQYSRT (Table 1), with 
high affinity for undifferentiated ESCs. They subsequently conjugated the peptide to 
CdSe-ZnS QDs (Figure 6-c1) and showed that the conjugates could bind efficiently and 
selectively to ESCs, with no binding observed for other cell types (primary mouse 
embryonic fibroblast, PMEF, Figure 6-c3) and ESCs from other species (mouse ESCs, 
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Figure 6-c5), or when control QDs were used (Figure 6-c4, c6). The E7 peptide (Table 
1), known to bind hMSCs, was conjugated to gadolinium(Gd)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) for labeling MSCs for MRI 
(101). In-vitro studies showed Gd-DOTA-E7 yielded minimum labeling efficacy, but 
good contrast enhancement.   
Identification of peptides that interact with stage-specific cellular targets (e.g., 
differentiation stage) would be useful for assessing molecular profiles of cells in-vivo 
(e.g., imaging differentiation of transplanted cells). Zhao et al. (59) identified a peptide 
with the ability to bind NSCs derived from rhesus monkey ESCs, and used this peptide 
combined with QDs for cell imaging. This study described for the first time the use of 
phage-derived peptides for studying ESC differentiation by optical imaging.  
A problem with these imaging agents is that the signal cannot be used to distinguish 
live from dead cells, and is not certain whether or not these probes will be retained by 
cells in the long term. Previous studies indicated that after cell death, contrast agents 
can be passed to host cells, producing false positives (102, 103). Thus, monitoring stem 
cell fate may require a combination of complementary imaging methods, such as 
fluorescence and magnetic resonance, to allow the correlation between anatomical 
localization of labeled stem cells and cell viability. Reporter genes represent a potential 
solution to this issue, although this can pose additional safety and regulatory 
problems. Phage display could also contribute towards the development of molecular 
probes that would bind only viable cells resulting in the release of the label after cell 
death. Since dead cells have a compromised cell membrane, it might be possible to 
identify a specific ligand for live cells by panning on dead cells first (pre-clearing).  
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 Figure 6. The application of phage-derived peptides for targeted imaging of cells and tissues in-vitro 
and in-vivo. (a) Collagen I-specific probe based on collagen-binding peptide displayed on dendrimer 
edges; (a1) Collagen-binding peptide displayed on dendrimer edges resembling the typical pentavalent 
structure of phages. Laser scanning confocal microscopy images of pig parietal pericardium incubated 
with: (a2) 0.6 μM fluorescein-labeled peptide pentamer; (a3, a4) fluorescein-labeled monovalent 
collagen binding peptide at 0.6 μM and 60 μM; (a5-a7) 6 μM AlexaFluor568-labeled CNA35 (red) 
followed by 0.6 μM fluorescein-labeled peptide pentamer (green) (co-staining). Adapted with 
permission from ref. (38). Copyright 2009 American Chemical Society. (b) Detection of VCAM-1 by MRI 
and fluorescence imaging using VCAM-1-binding peptide (VP) and multimodal nanoparticles (VNPs) in 
atherosclerotic lesions. Intravital confocal microscopy images of mouse ear with (b1, b3) or without (b2, 
b4) mTNF-α-induced inflammation at 4 (b1, b2) and 24 h (b3, b4) after intravenous injection of VNP 
(red). Green color in the images is due to the tissue autofluorescence; Images obtained from the 3D 
stack reconstruction of the Z series (b5) from (b3) and of the time series (b6) of VNP staining within the 
vessels (each time point is shown as an individual slice in the Z direction and the level of peptide staining 
(low to high) is given by the color scheme (blue to green)). In-vivo (b7) and ex-vivo (b8) MRI of the aorta 
of cholesterol-fed apoE
_/_
 mice using gadolinium-protected graft copolymer (Gd-PGC) shows defined 
vascular lumen and aortic abnormalities such as narrowing (b7, arrows) and low signal changes caused 
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by VNP localization (arrows, b8); (b9) Epifluorescence image of excised aorta using fluorescent labeled 
peptide confirming details observed in (b8); (b10, b11) Immunofluorescence images of aorta sections 
revealing co-localization of VCAM-1 (green) and VNP (red). Nuclei in b10 and b11 are stained with DAPI 
(blue). Bars = 10 µm. Adapted with permission from Lippincott Williams and Wilkins/Wolters Kluwer 
Health: Circulation Research (67), copyright 2005. (c) Targeted imaging of ESCs using peptide-conjugated 
QDs. (c1) Schematic of CdSe-ZnS QDs conjugated with APWHLSSQYSRT peptide (green sphere); (c2) 
Fluorescence and bright-field microscopy images of ESCs (cell nuclei in blue, Hoechest 33258) after 
incubation with peptide-QDs (red) showing their binding to ESC colonies (inside dashed line); (c3) 
Fluorescence microscopy image of peptide-QDs with PMEF cells which are used as a feeder layer 
(outside dashed line); (c4, c6) Fluorescence microscopy images of cells with free QDs (without 
conjugated peptides, control); (c5) Fluorescence microscopy images mESCs peptide-conjugated QDs; 
Adapted with permission from ref. (56). Copyright 2010 PlosOne.   
 
CONCLUDING REMARKS AND OUTLOOK 
The ability to display a large and highly diverse collection of random peptide sequences 
on the coat-proteins of phages offers the possibility to discover new interactions with 
useful targets, often without knowing their structure. The field of phage display 
technology has evolved significantly from when it was first developed for mapping 
interactions between proteins, and has expanded into other areas that benefit from 
the discovery of new interacting ligands. This review demonstrates the usefulness of 
phage display in the emerging field of RM, suggesting opportunities for further 
applications. However, we must consider the challenges associated with phage-derived 
peptides before their translation into useful RM tools. When used as linear monomers, 
isolated peptide ligands usually show poor affinity for their targets, as this 
presentation differs significantly from the original display (valency and orientation) on 
the phage particles. Multimerization (conjugation of multiple peptide copies to a 
surface of a nanoparticle, like dendrimers, liposomes, or micelles) has been proven to 
increase affinity of the ligand for its targets, but the affinity of these multivalent 
peptide platforms also depends on the density of receptors on the cell periphery. In 
addition, when displayed on the phage, peptides are fused to the coat protein through 
the C-terminus and have a free N-terminus. This feature is not always taking into 
account when presenting phage-derived peptides into multivalent carriers. This 
stresses the importance of the use of biomaterials engineering to enable the peptides 
to be displayed in the precise and optimal multimeric conformation for interaction 
with cell receptors. Presenting peptides within a biomaterials platform also provides 
protection against proteolytic degradation, which is essential for prolonging their half-
life in-vivo. 
It should be noted that many of the sequences described in this review were obtained 
from targets derived from multiple species. Thus, it is necessary to confirm if these 
peptides also bind to the same targets in humans. Although cell-binding peptides can 
be used without knowing their specific receptors, identification of their cellular targets 
is essential for gaining clinical approval, as emphasized by Gray and Brown (100). It is 
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also useful for obtaining information about the heterogeneity of the protein repertoire 
on the cell surface and how it varies among cell types and states.  
To accelerate the safe application of phage-derived peptides within the field of RM, 
the next logical steps will be their further optimization and validation in-vitro and in-
vivo, in terms of affinity, specificity, activity, stability, and biodistribution.  
While binding has been the basis for peptide screening in phage display, selection 
based on function might be useful for certain RM approaches (e.g. controlled stem cell 
differentiation). In a recent perspective article (104), Lerner highlighted the potential 
of intracellular combinatorial (unbiased) antibody libraries as a discovery tool to select 
antibodies able to bind unknown receptors or to identify new roles of common 
receptors. They showed that infection of BMSCs with unbiased libraries led to the 
selection of various antibody agonists that induced proliferation of cells, or 
proliferation followed by differentiation or trans-differentiation into neural cells, 
indicating new roles for identified receptors in differentiation. These studies suggest 
new ways to regulate cell fates by selecting cell-binding antibodies or peptides on the 
basis of function (e.g., ability to activate a given receptor involved in inducing 
differentiation).  
With further advances in biology and RM, there are enormous opportunities for phage 
display to contribute tools for research and applications in such fields. Led by a vibrant 
research community in biology and RM, phage display technology will have a broad 
range of applications in the future. 
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Ad: adenovirus: ALP: alkaline phosphatase; ASCs: adipose stromal cells; ATs: alkanethiols; BC-
1: bifunctional peptide 1; BRASIL: biopanning and rapid analysis of selective interactive 
ligands; bFGF: basic fibroblast growth factor; BMHP: bone marrow homing peptide; BMP-2: 
bone morphogenetic protein 2; BMSCs: bone marrow stem cells; C3: complement 3; CAP: 
chondrocyte-affinity peptide; cBMHP: cyclic BMHP; cDNA: complementary DNA; Col: collagen; 
DMEM: Dulbecco's modified eagle medium; DNA: deoxyribonucleic acid; DOTA: 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid; ds: double stranded; EC50: half maximal 
effective concentration; ECM: extracellular matrix; ELISA: enzyme-linked immunosorbent 
assay; ESCs: embryonic stem cells; FDA: US Food and Drug Administration; FITC: Fluorescein 
isothiocyanate; GAG: glycosaminoglycan; Gd-PGC: gadolinium-protected graft copolymer; GF: 
growth factor; GFP: green fluorescent protein; HA: hyaluronic acid (or hyaluronan); HAB: high 
affinity binding; hACs: human articular chondrocytes; HAP: hydroxyapatite; H&E: hematoxylin 
and eosin; HUVECs: human umbilical vein endothelial cells; IC50: half inhibitory concentration; 
IL-1: interleukin 1; IL-10: interleukin 10; KD: dissociation constant; LAB: low affinity binding; 
MRI: magnetic resonance imaging; mRNA: messenger RNA; MSCs: mesenchymal stem cells; 
mTNF-α: murine TNF-α; NGS: next generation sequencing; NLS: nuclear localization signal; 
NPCs: neural progenitor cells; NSCs: neural stem cells; OA: osteoarthritis; ODM: osteogenic 
differentiation medium: PA: peptide amphiphile; PAMAM: poly(amido)amine; PCL: 
polycaprolactone; pDNA: plasmid DNA; PEG: polyethyleneglycol PEI: polyethyleneimine; PET: 
positron emission tomography: PMEF: primary mouse embryonic fibroblast; QDs: quantum-
dots; RGD: arginine-glycine-aspartic acid; rhBMP-2: recombinant form of human BMP-2; RM: 
regenerative medicine; RHAMM: receptor for hyaluronan-mediated motility; rMSC: rat MSCs; 
RNA: ribonucleic acid; RNAi: RNA interference; S2P: stabilin-2 peptide; SA: streptavidin; SAM: 
self-assembled monolayer; SEM: scanning electron microscopy; siRNA: small interfering RNA; 
SPACE: skin permeating and cell entering; ss: single stranded; TGF-βR: transforming growth 
factor β receptor; TGF-β: transforming growth factor β; TNF: tumor necrosis factor; VCAM-1: 
vascular cell adhesion molecule 1; VNP: VHSPNKK-modified magnetofluorescent nanoparticle. 
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